Home » News » India » Nepal Approves AstraZeneca Covid-19 Vaccine Manufactured in India for Emergency Use: Report
1-MIN READ

Nepal Approves AstraZeneca Covid-19 Vaccine Manufactured in India for Emergency Use: Report

Reuters

Last Updated: January 15, 2021, 17:07 IST

Kathmandu

Representative image.

Representative image.

Nepal has reported 266,816 cases and 1,948 deaths from COVID-19 so far, according to official data.

Nepal on Friday granted approval for AstraZeneca’s COVISHIELD vaccine against the novel coronavirus in the country.

“Conditional permission has been granted for emergency use authorization of COVISHIELD vaccine against COVID-19 in Nepal,” a statement by the country’s Department of Drug Administration said.

Nepal has reported 266,816 cases and 1,948 deaths from COVID-19 so far, according to official data.

Read all the Latest News, Breaking News and Coronavirus News here

first published:January 15, 2021, 17:07 IST
last updated:January 15, 2021, 17:07 IST